Candida and Candidiasis Conference 2023

2023 年念珠菌和念珠菌病会议

• 批准号: 10682982
• 负责人: Richard John Bennett
• 金额: $ 0.7万
• 依托单位: BROWN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-08 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10682982
• 关键词: Address; Affect; Agreement; American; Antifungal Agents; Area; Biological; Biology; Blood Circulation; COVID-19 pandemic; CRISPR/Cas technology; Canada; Candida; Candida albicans; Candida auris; Candidiasis; Cell Communication; Cessation of life; Clinic; Clinical; Clinical Treatment; Collaborations; Communities; Consensus; DNA cassette; Development; Diagnosis; Disease; Drug resistance; Elevator; Epidemiology; Event; Faculty; Feedback; Female; Fostering; Funding; Gene Deletion; Genetic; Genomics; Goals; Human; Hybrids; Immune response; Immunology; Infection; Inflammation; Interdisciplinary Study; International; Invaded; Life; Medical; Methodology; Microbiology; Modeling; Mouth Diseases; Mucous Membrane; Multi-Drug Resistance; Mycoses; Oral; Oral candidiasis; Participant; Persons; Play; Positioning Attribute; Postdoctoral Fellow; Proteomics; Publications; Quebec; Recording of previous events; Reporting; Research; Research Personnel; Role; Running; San Francisco; Schedule; Scientist; Seminal; Sexual Reproduction; Societies; Speed; Structure; Students; Surveys; Systemic infection; Systems Biology; Technology; The science of Mycology; Therapeutic; Thinking; Time; Tissues; Toxin; Underrepresented Minority; Work; candidemia; career; career development; cost; design; drug development; emerging pathogen; experience; graduate student; interest; meetings; member; microbiome; next generation; novel therapeutic intervention; pathogen; pathogenic fungus; posters; professor; programs; research and development; scientific organization; success; symposium; tool; transcriptomics; translational scientist; vaginal candidiasis; virtual

Project Summary Fungal infections affect more than a billion people each year, of which 150 million cases are severe or life- threatening infections that result in 1.7 million deaths. Candida species are the major cause of life- threatening fungal disease in nosocomial settings, and cause a wide variety of diseases from oral and vaginal candidiasis to bloodstream candidemia. Research into Candida biology addresses a broad spectrum of topics relating to epidemiology, drug resistance, host response, and therapeutics. The Candida and Candidiasis Conference has been held every two to three years since 1987. This conference is the premier forum for the Candida community to assemble and to discuss the latest research in all areas of Candida biology, including emerging species of concern such as the multidrug resistant species Candida auris. Funds are requested for support towards for the 2023 Candida and Candidiasis conference to be held May 13-17 at the Le Centre Sheraton hotel in Montreal, Canada. This meeting will be run with the support of the Microbiological Society who are experienced with the organizing of scientific conferences. It is envisaged that 300-350 U.S. and international scientists will attend this meeting in person, and the conference has received enthusiastic support from the community and from past surveys of participants. The 2023 iteration of the conference is particularly important given that the 2020 conference was cancelled and held remotely (only) in 2021. The Program includes 8 main sessions with 6 speakers in each, as well as 3 parallel sessions and 2 elevator sessions. These sessions are designed to provide as much opportunity as possible for junior investigators (students, postdocs and junior professors) to give oral presentations to the community. At least 60 of the talks for the main and parallel sessions will be selected based on submitted abstracts. Elevator sessions will allow a further 37 junior scientists to summarize their research in short talks on the main stage. There will also be three poster sessions will allow discussion of the expected 200-300 posters. The main talks will also be recorded and made available online for those unable to attend the conference in person, which will expand the accessibility of the meeting worldwide. Clinical sessions are also a key part of the meeting as the conference seeks to foster interactions between basic and translational researchers. These sessions will bring the community up to speed in the challenges of diagnosing and treating Candida infections in nosocomial settings. The Candida and Candidiasis meeting has a strong track record of inclusion, with 50% of the session chairs being female while we also encourage and support attendance from underrepresented minorities. We are confident that the conference will promote synergistic and interdisciplinary interactions between all members of the research community, and will drive research into Candida biology and help develop new therapeutic approaches.

项目摘要 真菌感染每年影响超过十亿人，其中1.5亿例严重或寿命 - 威胁感染，导致170万人死亡。念珠菌是生命的主要原因 - 在医院环境中威胁真菌疾病，并引起口服和 阴道念珠菌病至血液念珠菌。念珠菌生物学的研究涉及广泛的 与流行病学，耐药性，宿主反应和治疗学有关的主题范围。 自1987年以来，念珠菌和念珠菌病大会每两到三年举行一次。 会议是念珠菌社区组装和讨论最新研究的主要论坛 在念珠菌生物学的所有领域，包括新兴物种，例如耐多药 物种念珠菌。要求资金支持2023年的念珠菌和念珠菌病 会议将于5月13日至17日在加拿大蒙特利尔的LE Center Sheraton酒店举行。这次会议将是 在经验丰富的科学组织的微生物学会的支持下运行 会议。可以预见，美国和国际科学家将参加这次会议 人，会议得到了社区和过去调查的热情支持 参与者。鉴于2020年会议，2023年的迭代尤其重要 被取消并在2021年被远程保留。 该程序包括8个主要会议，每个会议中有6位扬声器，以及3个平行会议和2个 电梯会议。这些会议旨在为初中提供尽可能多的机会 调查人员（学生，博士后和初级教授）向社区进行口头介绍。在 将根据提交的摘要选择主要和并行会议的60个对话。 电梯会议将允许另外37位初级科学家在简短的谈判中总结他们的研究 主要舞台。还将有三个海报会议允许讨论预期的200-300海报。 还将记录主要会谈并在线录制，以便无法参加会议的人 人，将扩大全球会议的可访问性。 临床会议也是会议的关键部分，因为会议试图促进 基本和翻译研究人员。这些会议将使社区加快挑战 在医院环境中诊断和治疗念珠菌感染。念珠菌和念珠菌病 会议的包容性有很强的记录，其中50％的会议椅为女性，而我们也是 鼓励和支持代表性不足的少数群体的出勤。我们有信心会议 将促进研究界所有成员之间的协同和跨学科互动， 并将推动研究念珠菌生物学的研究，并帮助开发新的治疗方法。